| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 25mg |
|
||
| 50mg |
|
||
| 100mg |
|
||
| 250mg | |||
| Other Sizes |
| Targets |
DUBs-IN-1 targets ubiquitin-specific protease 8 (USP8) with an IC50 of 0.85 μM. It is highly selective for USP8 over USP7, with an IC50 of >100 μM for USP7. By inhibiting USP8, it modulates protein degradation pathways and affects cell viability.
|
|---|---|
| ln Vitro |
DUBs-IN-1 (22 d) exhibits an IC50 of 0.85 μM against USP8, making it an effective inhibitor of ubiquitin-specific proteases. When it comes to USP7 (IC50, >100 μM), DUBs-IN-1 is inactive. DUBs-IN-1 and its derivatives, with IC50 values ranging from 0.5 μM to 1.5 μM, have the ability to decrease the viability of the HCT116 colon cancer cell line and the PC-3 prostate cancer cell line [1].
In vitro, DUBs-IN-1 exhibits an IC50 of 0.85 μM against USP8. It is inactive against USP7 (IC50 >100 μM). DUBs-IN-1 and its derivatives decrease the viability of HCT116 colon cancer cells and PC-3 prostate cancer cells, with IC50 values ranging from 0.5 μM to 1.5 μM. |
| ln Vivo |
In vivo, DUBs-IN-1 is used as a research tool to study the role of USP8 in various biological processes. Specific standalone in vivo efficacy data for this compound are not extensively published.
|
| Enzyme Assay |
DUBs-IN-1 is soluble in DMSO at ~100 mg/mL. For in vivo studies, it can be formulated in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% saline or in 10% DMSO + 90% corn oil. Powder is stable for up to 3 years at -20°C.
|
| Cell Assay |
In vitro cell-based assays for DUBs-IN-1 utilize cancer cell lines such as HCT116 and PC-3. Cells are treated with the compound, and cell viability is assessed by MTT or CellTiter-Glo assays.
|
| References | |
| Additional Infomation |
DUBs-IN-1 is a research compound with no clinical approval. It is a valuable tool for studying USP8 biology and the role of deubiquitination in cancer and other diseases. It is used in drug discovery programs to explore the therapeutic potential of USP8 inhibitors.
|
| Molecular Formula |
C20H11N5O
|
|---|---|
| Molecular Weight |
337.33424
|
| Exact Mass |
337.096
|
| CAS # |
924296-18-4
|
| PubChem CID |
16065490
|
| Appearance |
Light yellow to yellow solid powder
|
| Density |
1.32g/cm3
|
| Boiling Point |
632.2ºC at 760 mmHg
|
| Flash Point |
336.2ºC
|
| Index of Refraction |
1.704
|
| LogP |
3.169
|
| Hydrogen Bond Donor Count |
0
|
| Hydrogen Bond Acceptor Count |
6
|
| Rotatable Bond Count |
3
|
| Heavy Atom Count |
26
|
| Complexity |
637
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
C1=CC=C(C=C1)CO/N=C/2\C3=CC=CC=C3C4=NC(=C(N=C42)C#N)C#N
|
| InChi Key |
GKOWDIBLCDZJHF-NCELDCMTSA-N
|
| InChi Code |
InChI=1S/C20H11N5O/c21-10-16-17(11-22)24-20-18(23-16)14-8-4-5-9-15(14)19(20)25-26-12-13-6-2-1-3-7-13/h1-9H,12H2/b25-19+
|
| Chemical Name |
(9E)-9-phenylmethoxyiminoindeno[1,2-b]pyrazine-2,3-dicarbonitrile
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~100 mg/mL (~296.45 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 2.5 mg/mL (7.41 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (7.41 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.9645 mL | 14.8223 mL | 29.6446 mL | |
| 5 mM | 0.5929 mL | 2.9645 mL | 5.9289 mL | |
| 10 mM | 0.2964 mL | 1.4822 mL | 2.9645 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
